Medicare Enrolled

Dr. Motaz Agabani, MD

Endocrinology · Sarasota, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2650 BAHIA VISTA, Sarasota, FL 34239
9413308355
Registered in NPPES since 2006
NPI: 1750479952 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Agabani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agabani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Agabani

Dr. Motaz Agabani is an endocrinology specialist in Sarasota, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Agabani performed 1,969 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Agabani received a total of $5,531 from 45 pharmaceutical and/or device companies across 280 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Agabani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 29% volume in FL $5,531 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 75756 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,969
Medicare services
Top 29% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,448 $90 $178
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
198 $27 $98
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
120 $77 $175
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
104 $120 $300
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
29 $49 $150
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
28 $101 $320
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
26 $95 $360
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $62 $120
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,531
Total received (2018-2024)
Avg $790/year across 7 years
Top 41% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
280
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$739
2023
$770
2022
$794
2021
$964
2020
$688
2019
$665
2018
$911

Payments by company (2024)

Dexcom, Inc.
$89
RECORDATI_RARE_DISEASES_INC.
$81
Amneal Pharmaceuticals LLC
$73
Kyowa Kirin, Inc.
$70
Xeris Pharmaceuticals, Inc.
$65
Tandem Diabetes Care, Inc.
$57
Insulet Corporation
$53
Abbott Laboratories
$40
BETA BIONICS, INC.
$40
ABBVIE INC.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Novo Nordisk Inc
$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$20
Amgen Inc.
$20
Nevro Corp.
$19
Acella Pharmaceuticals, LLC
$15
Top 3 companies account for 32.9% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$364
Abbott Laboratories
$338
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$335
Novo Nordisk Inc
$306
Boehringer Ingelheim Pharmaceuticals, Inc.
$286
AstraZeneca Pharmaceuticals LP
$269
Janssen Pharmaceuticals, Inc
$241
Merck Sharp & Dohme Corporation
$238
Dexcom, Inc.
$222
Amneal Pharmaceuticals LLC
$217
Medtronic MiniMed, Inc.
$194
Radius Health, Inc.
$188
Insulet Corporation
$188
Xeris Pharmaceuticals, Inc.
$185
IBSA Pharma Inc.
$176
Bayer HealthCare Pharmaceuticals Inc.
$166
Lilly USA, LLC
$158
AbbVie Inc.
$129
LIFESCAN, INC.
$121
ABBVIE INC.
$112
AbbVie, Inc.
$107
LifeScan, Inc.
$98
Amgen Inc.
$92
RECORDATI_RARE_DISEASES_INC.
$81
DEXCOM, INC.
$72
Kyowa Kirin, Inc.
$70
Ultragenyx Pharmaceutical Inc.
$69
Ipsen Biopharmaceuticals, Inc
$67
Tandem Diabetes Care, Inc.
$57
Bayer Healthcare Pharmaceuticals Inc.
$54
BETA BIONICS, INC.
$40
Merck Sharp & Dohme LLC
$40
Takeda Pharmaceuticals U.S.A., Inc.
$39
Regeneron Healthcare Solutions, Inc.
$32
Alexion Pharmaceuticals, Inc.
$20
Nevro Corp.
$19
Sun Pharmaceutical Industries Inc.
$17
CeQur Corporation
$17
Clarus Therapeutics Inc.
$17
Horizon Therapeutics plc
$17
Ferring Pharmaceuticals Inc.
$16
MannKind Corporation
$15
Acella Pharmaceuticals, LLC
$15
Aytu BioScience, Inc
$13
Senseonics, Incorporated
$10
Top 3 companies account for 18.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · LICART · Minimed 630G · Minimed 670G System · NP Thyroid 60 · Natesto · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · Omnipod · One Touch Reveal Mobile App · OneTouch · OneTouch Verio Reflect · Ozempic · PRALUENT ALIROCUMAB INJECTION · Prolia · RIOMET ER · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLATRO · SYNTHROID · Senza · Somatuline Depot · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tirosint · Tymlos · UBRELVY · UNITHROID · Victoza · Xultophy 100/3.6 · ZOMACTON · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Sarasota?
Compare endocrinologists in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
24
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
SARASOTA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Agabani is a clinical cardiology specialist, with above-average Medicare volume (top 29% in FL), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Agabani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Agabani performed 1,448 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Agabani receive payments from pharmaceutical companies?
Yes. Dr. Agabani received a total of $5,531 from 45 companies across 280 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agabani's costs compare to other endocrinologists in Sarasota?
Dr. Agabani's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agabani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →